Palvella Therapeutics (PVLA) Cash From Operations

Annual CFO

-$13.70 M
+$1.14 M+7.66%

December 1, 2023

Summary

Performance

1-Year Change

+7.66%

3-Year Change

+7.66%

5-Year Change

+7.66%

15-Year Change

+7.66%

PVLA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$13.70 M
PVLA annual cash flow from operations is currently at an all-time high

3-Year Low

-$14.84 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
PVLA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
PVLA next annual earnings announcement has not yet been scheduled

OtherPVLAcash flowmetrics:

Annual CFI

-
PVLA annual cash flow from investing activities value is unknown

Annual CFF

$5.00 M
PVLA annual cash flow from financing activities is $5.00 million

Annual FCF

-$13.70 M
PVLA annual free cash flow is -$13.70 million

Annual CAPEX

-
PVLA annual capital expenditures value is unknown

Quarterly CFO

-$1.10 M
+$2.85 M+72.13%

March 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+72.13%

3-Year Change

+72.13%

5-Year Change

+72.13%

PVLA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.10 M
PVLA quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$3.95 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 1, 2024
PVLA previous earnings announcement was published on Mar 1, 2024

Next Quarterly Earnings Report Date

N/A
PVLA next earnings announcement has not yet been scheduled

OtherPVLAcash flowmetrics:

Quarterly CFI

-
PVLA quarterly cash flow from investing activities value is unknown

Quarterly CFF

-
PVLA quarterly cash flow from financing activities value is unknown

Quarterly FCF

-$1.10 M
PVLA quarterly free cash flow is -$1.10 million

Quarterly CAPEX

-
PVLA quarterly capital expenditures value is unknown

TTM CFO

-$1.10 M
+$2.85 M+72.13%

March 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+72.13%

3-Year Change

+72.13%

5-Year Change

+72.13%

PVLA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.10 M
PVLA TTM cash flow from operations is currently at an all-time high

3-Year Low

-$3.95 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 1, 2024
PVLA previous earnings announcement was published on Mar 1, 2024

Next Quarterly Earnings Report Date

N/A
PVLA next earnings announcement has not yet been scheduled

OtherPVLAcash flowmetrics:

TTM CFI

-
PVLA TTM cash flow from investing activities value is unknown

TTM CFF

-
PVLA TTM cash flow from financing activities value is unknown

TTM FCF

-$1.10 M
PVLA TTM free cash flow is -$1.10 million

TTM CAPEX

-
PVLA TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PVLA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.7%+72.1%+72.1%
3 y3 years+7.7%+72.1%+72.1%
5 y5 years+7.7%+72.1%+72.1%

PVLA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+8.3%at high+258.8%at high+258.8%
5 y5-yearat high+8.3%at high+258.8%at high+258.8%
alltimeall timeat high+8.3%at high+258.8%at high+258.8%

Palvella Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Mar 2024
-
-$1.10 M(-72.1%)
-$1.10 M(-72.1%)
Dec 2023
-$13.70 M
-
-
DateAnnualQuarterlyTTM
Mar 2023
-
-$3.95 M
-$3.95 M
Dec 2022
-$14.84 M
-
-

FAQ

  • What is Palvella Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Palvella Therapeutics?
  • What is Palvella Therapeutics annual CFO year-on-year change?
  • What is Palvella Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Palvella Therapeutics?
  • What is Palvella Therapeutics quarterly CFO year-on-year change?
  • What is Palvella Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Palvella Therapeutics?
  • What is Palvella Therapeutics TTM CFO year-on-year change?

What is Palvella Therapeutics annual cash flow from operations?

The current annual CFO of PVLA is -$13.70 M

What is the all time high annual CFO for Palvella Therapeutics?

Palvella Therapeutics all-time high annual cash flow from operations is -$13.70 M

What is Palvella Therapeutics annual CFO year-on-year change?

Over the past year, PVLA annual cash flow from operations has changed by +$1.14 M (+7.66%)

What is Palvella Therapeutics quarterly cash flow from operations?

The current quarterly CFO of PVLA is -$1.10 M

What is the all time high quarterly CFO for Palvella Therapeutics?

Palvella Therapeutics all-time high quarterly cash flow from operations is -$1.10 M

What is Palvella Therapeutics quarterly CFO year-on-year change?

Over the past year, PVLA quarterly cash flow from operations has changed by +$2.85 M (+72.13%)

What is Palvella Therapeutics TTM cash flow from operations?

The current TTM CFO of PVLA is -$1.10 M

What is the all time high TTM CFO for Palvella Therapeutics?

Palvella Therapeutics all-time high TTM cash flow from operations is -$1.10 M

What is Palvella Therapeutics TTM CFO year-on-year change?

Over the past year, PVLA TTM cash flow from operations has changed by +$2.85 M (+72.13%)